[Diagnosis and management of eosinophilic esophagitis].

Rev Med Chil

Escuela Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

Published: June 2020

AI Article Synopsis

  • Eosinophilic esophagitis (EoE) is a chronic immune disorder primarily triggered by food allergens, leading to symptoms like dysphagia, food impaction, and abdominal pain, and has increasing prevalence among both children and adults.
  • Diagnosis involves endoscopic biopsies showing greater than 15 eosinophils per high power field, and the disease is often associated with other allergic conditions like asthma and eczema.
  • Treatment options include dietary changes, medications such as proton pump inhibitors (PPIs), and esophageal dilation, with early diagnosis and intervention being crucial to prevent complications like esophageal stenosis.

Article Abstract

Eosinophilic esophagitis (EoE) is a chronic, immune-mediated disease, induced by food allergens, clinically characterized by symptoms of esophageal dysfunction. Pathologically there is a predominant eosinophilic inflammation. This disease is relatively new, and its definitions have evolved over time. Its prevalence and incidence are increasing and causes clinical problems both in children and adults. Its symptoms include food impaction, dysphagia, symptoms that resemble gastroesophageal reflux, abdominal pain, and vomiting. It can also have extra-digestive symptoms such as rhinosinusitis, chronic cough, recurrent croup and hoarseness. EoE can be associated with other atopic conditions, such as asthma, eczema and food allergies. The diagnosis is made by the analysis of endoscopic biopsies (> 15 eosinophils per high power field). Proton pump inhibitors (PPIs) are currently accepted as a treatment for EoE. The clinical and pathological improvement with the use PPIs ceased to be a criterion to define Esophageal eosinophilia responsive to PPIs as a differential diagnosis, since this condition is currently considered within the EoE spectrum. There are three main treatment approaches for EoE: diet, drugs and dilation. Its diagnosis and early treatment are key to avoid or delay its complications, such as stenosis and severe esophageal dysfunction.

Download full-text PDF

Source
http://dx.doi.org/10.4067/S0034-98872020000600831DOI Listing

Publication Analysis

Top Keywords

esophageal dysfunction
8
eoe
5
[diagnosis management
4
management eosinophilic
4
eosinophilic esophagitis]
4
esophagitis] eosinophilic
4
eosinophilic esophagitis
4
esophagitis eoe
4
eoe chronic
4
chronic immune-mediated
4

Similar Publications

Esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC) are distinct histological subtypes of esophageal cancer. The tumor microenvironment of each subtype significantly influences the efficacy of immunotherapy. However, the characteristics of the tumor microenvironments of both subtypes, as well as their specific impacts on immunotherapy outcomes, still require further elucidation.

View Article and Find Full Text PDF

Background: Esophageal cancer (ESC) is an aggressive disease which often presents at an advanced stage. Despite trimodal therapy, 40-50% patients can develop metastatic disease by 18 months. Identification of patients at risk for metastatic spread is challenging with need for improved prognostication.

View Article and Find Full Text PDF

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

Yonsei University, Wonju, Gangwon-do, Korea, Republic of (South).

Background: Dysphagia can increase fear of swallowing, reduce self-esteem, and hinder social relationships. Such factors can also increase anxiety and degrade the quality of life. This study aimed to elucidate the association between dysphagia and depressive symptoms.

View Article and Find Full Text PDF

Esophageal cancer (ESCA) is a common tumor noted in the digestive tract, which is highly malignant due to unclear early symptoms and poor last‑stage treatment effects; its mortality rate is relatively high. MicroRNA (miR) and signal transducer and activator of transcription 3 (STAT3) are key components of cellular signaling pathways; their interaction forms a complex and intricate information network that controls several types of biological behaviors in the cells. In the tumor cell, these signal transduction pathways are abnormally active, indicating that the STAT3 signaling pathway mediated by miRs is involved in the progression of various cancer types.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!